These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8589129)

  • 1. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms.
    Jacobson KL; Cohen SH; Inciardi JF; King JH; Lippert WE; Iglesias T; VanCouwenberghe CJ
    Clin Infect Dis; 1995 Nov; 21(5):1107-13. PubMed ID: 8589129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior antimicrobial therapy and resistance of Enterobacter Citrobacter and Serratia to third generation cephalosporins.
    Nicolle LE
    J Hosp Infect; 1988 May; 11(4):321-7. PubMed ID: 2899583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
    Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical consequences of development of resistance to third generation cephalosporins.
    Follath F; Costa E; Thommen A; Frei R; Burdeska A; Meyer J
    Eur J Clin Microbiol; 1987 Aug; 6(4):446-50. PubMed ID: 3117534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ceftazidime on enterobacteria and Pseudomonas producers of beta-lactamases].
    Chabbert YA; Derlot E; Courvalin P
    Pathol Biol (Paris); 1985 Sep; 33(7):758-63. PubMed ID: 3936006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review.
    Mizrahi A; Delerue T; Morel H; Le Monnier A; Carbonnelle E; Pilmis B; Zahar JR;
    Int J Antimicrob Agents; 2020 Feb; 55(2):105834. PubMed ID: 31682902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.
    Thomson KS; Sanders CC; Moland ES
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1393-400. PubMed ID: 10348759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use.
    Choi SH; Lee JE; Park SJ; Choi SH; Lee SO; Jeong JY; Kim MN; Woo JH; Kim YS
    Antimicrob Agents Chemother; 2008 Mar; 52(3):995-1000. PubMed ID: 18086837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.
    Jones RN
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):461-6. PubMed ID: 9635237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
    Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
    J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.
    Tamma PD; Girdwood SC; Gopaul R; Tekle T; Roberts AA; Harris AD; Cosgrove SE; Carroll KC
    Clin Infect Dis; 2013 Sep; 57(6):781-8. PubMed ID: 23759352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
    Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
    Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital, Uganda.
    Kateregga JN; Kantume R; Atuhaire C; Lubowa MN; Ndukui JG
    BMC Pharmacol Toxicol; 2015 Jun; 16():14. PubMed ID: 26031914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
    Piddock LJ; Traynor EA
    J Antimicrob Chemother; 1991 Aug; 28(2):209-19. PubMed ID: 1778852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.
    Lee SO; Kim YS; Kim BN; Kim MN; Woo JH; Ryu J
    Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):577-81. PubMed ID: 12226687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
    Rogers DT; Russell AD
    J Appl Bacteriol; 1980 Aug; 49(1):111-8. PubMed ID: 6776086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.